Growth Metrics

Cabaletta Bio (CABA) Non-cash Items (2018 - 2025)

Cabaletta Bio's quarterly Non-cash Items came in at $7.9 million in Q4 2025, up 794703.84% year-on-year from N/an in Q4 2024, and up 169.85% quarter-over-quarter from $2.9 million in Q3 2025.

Cabaletta Bio has reported Non-cash Items for 8 years, with the latest figure at $7.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 794703.84% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (up 794703.84% YoY), and the FY2025 full-year result was $7.9 million, up 39.31% from the prior year.
  • Non-cash Items for Q4 2025 stood at $7.9 million, up from $2.9 million in the prior quarter.
  • The five-year high for Non-cash Items was $58.9 million in Q3 2023, with the low at $989.0 in Q4 2024.
  • Average Non-cash Items over 5 years is $9.2 million, with a median of $4.5 million recorded in 2024.
  • Year-over-year, Non-cash Items sank 99.99% in 2021 and soared 937880.57% in 2022.
  • Tracing CABA's Non-cash Items over 5 years: stood at $2367.0 in 2021, then soared by 937880.57% to $22.2 million in 2022, then tumbled by 99.47% to $117384.0 in 2023, then tumbled by 99.16% to $989.0 in 2024, then jumped by 794703.84% to $7.9 million in 2025.
  • The last three Non-cash Items figures came in at $7.9 million (Q4 2025), $2.9 million (Q3 2025), and $408000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Cabaletta Bio 194.84 Mn 61.24 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 7.86 Mn
Dec 31, 2025 7.86 Mn
Sep 30, 2025 2.91 Mn
Sep 30, 2025 2.91 Mn
Jun 30, 2025 408,000.00
Jun 30, 2025 408,000.00
Mar 31, 2025 6.45 Mn
Mar 31, 2025 6.45 Mn
Dec 31, 2024 989.00
Dec 31, 2024 989.00
Sep 30, 2024 5.26 Mn
Sep 30, 2024 5.26 Mn
Jun 30, 2024 13.43 Mn
Jun 30, 2024 13.43 Mn
Mar 31, 2024 4.46 Mn
Mar 31, 2024 4.46 Mn
Dec 31, 2023 117,384.00
Dec 31, 2023 117,384.00
Sep 30, 2023 58.88 Mn
Sep 30, 2023 58.88 Mn
Jun 30, 2023 3.60 Mn
Jun 30, 2023 3.60 Mn
Mar 31, 2023 18.24 Mn
Mar 31, 2023 18.24 Mn
Dec 31, 2022 22.20 Mn
Dec 31, 2022 22.20 Mn
Jun 30, 2022 2.41 Mn
Jun 30, 2022 2.41 Mn
Mar 31, 2022 2.11 Mn
Mar 31, 2022 2.11 Mn
Dec 31, 2021 2,367.00
Dec 31, 2021 2,367.00
Sep 30, 2021 16.48 Mn
Sep 30, 2021 16.48 Mn
Jun 30, 2021 8.42 Mn
Jun 30, 2021 8.42 Mn
Mar 31, 2021 1.33 Mn
Mar 31, 2021 1.33 Mn
Dec 31, 2020 16.30 Mn
Dec 31, 2020 16.30 Mn
Sep 30, 2020 784,221.00
Sep 30, 2020 784,221.00
Jun 30, 2020 636,136.00
Jun 30, 2020 636,136.00
Mar 31, 2020 482,234.00
Mar 31, 2020 482,234.00
Dec 31, 2019 18.84 Mn
Dec 31, 2019 18.84 Mn
Sep 30, 2019 108,378.00
Sep 30, 2019 108,378.00
Dec 31, 2018 4.05 Mn
Dec 31, 2018 4.05 Mn